Oncothyreon Announces First Quarter 2013 Financial Results Conference Call

  Oncothyreon Announces First Quarter 2013 Financial Results Conference Call

PR Newswire

SEATTLE, WA, May 2, 2013

SEATTLE, WA, May 2, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY)  today 
announced that it will conduct a conference  call on Thursday, May 9, 2013  at 
4:30 p.m. Eastern Time (1:30 p.m.  Pacific) to discuss its first quarter  2013 
financial results  and  provide  a  review of  its  pipeline  of  products  in 
development.

To participate in the  call by telephone, please  dial (877) 280-7291  (United 
States) or  (707) 287-9361  (International).  In addition,  the call  will  be 
webcast live and can be accessed on  the "Events" page of the "News &  Events" 
section of Oncothyreon's  website at www.oncothyreon.com.  An archive of  the 
webcast will  be available  after completion  of the  discussion and  will  be 
posted on the Oncothyreon website.

About Oncothyreon

Oncothyreon is  a biotechnology  company specializing  in the  development  of 
innovative therapeutic  products for  the treatment  of cancer.  Oncothyreon's 
goal is to  develop and  commercialize novel synthetic  vaccines and  targeted 
small molecules that have the potential  to improve the lives and outcomes  of 
cancer patients. For more information, visit www.oncothyreon.com.

SOURCE Oncothyreon Inc.

Contact:

Investor and Media Relations Contact:
Julie Rathbun
Rathbun Communications
206-769-9219
ir@oncothyreon.com

ONCOTHYREON INC.
2601 Fourth Avenue, Suite 500
Seattle, WA 98121
Tel: (206) 801-2100
Fax: (206) 801-2101
http://www.oncothyreon.com